Cargando…

Nitric oxide production in the exhaled air of patients with pulmonary tuberculosis in relation to HIV co-infection

BACKGROUND: Nitric oxide (NO) is essential for host defense in rodents, but the role of NO during tuberculosis (TB) in man remains controversial. However, earlier observations that arginine supplementation facilitates anti-TB treatment, supports the hypothesis that NO is important in the host defens...

Descripción completa

Detalles Bibliográficos
Autores principales: Idh, Jonna, Westman, Anna, Elias, Daniel, Moges, Feleke, Getachew, Assefa, Gelaw, Aschalew, Sundqvist, Tommy, Forslund, Tony, Alemu, Addis, Ayele, Belete, Diro, Ermias, Melese, Endalkachew, Wondmikun, Yared, Britton, Sven, Stendahl, Olle, Schön, Thomas
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2596154/
https://www.ncbi.nlm.nih.gov/pubmed/18950489
http://dx.doi.org/10.1186/1471-2334-8-146
_version_ 1782161831495729152
author Idh, Jonna
Westman, Anna
Elias, Daniel
Moges, Feleke
Getachew, Assefa
Gelaw, Aschalew
Sundqvist, Tommy
Forslund, Tony
Alemu, Addis
Ayele, Belete
Diro, Ermias
Melese, Endalkachew
Wondmikun, Yared
Britton, Sven
Stendahl, Olle
Schön, Thomas
author_facet Idh, Jonna
Westman, Anna
Elias, Daniel
Moges, Feleke
Getachew, Assefa
Gelaw, Aschalew
Sundqvist, Tommy
Forslund, Tony
Alemu, Addis
Ayele, Belete
Diro, Ermias
Melese, Endalkachew
Wondmikun, Yared
Britton, Sven
Stendahl, Olle
Schön, Thomas
author_sort Idh, Jonna
collection PubMed
description BACKGROUND: Nitric oxide (NO) is essential for host defense in rodents, but the role of NO during tuberculosis (TB) in man remains controversial. However, earlier observations that arginine supplementation facilitates anti-TB treatment, supports the hypothesis that NO is important in the host defense against TB. Local production of NO measured in fractional exhaled air (FeNO) in TB patients with and without HIV co-infection has not been reported previously. Thus, our aim was to investigate levels of FeNO in relation to clinical symptoms and urinary NO metabolites (uNO). METHODS: In a cross sectional study, FeNO and uNO were measured and clinical symptoms, chest x-ray, together with serum levels of arginine, tumor necrosis factor alpha (TNF-alpha) and interleukin 12 (IL-12) were evaluated in sputum smear positive TB patients (HIV+/TB, n = 36, HIV-/TB, n = 59), their household contacts (n = 17) and blood donors (n = 46) from Gondar University Hospital, Ethiopia. RESULTS: The proportion of HIV-/TB patients with an increased FeNO level (> 25 ppb) was significantly higher as compared to HIV+/TB patients, but HIV+/TB patients had significantly higher uNO than HIV-/TB patients. HIV+ and HIV-/TB patients both had lower levels of FeNO compared to blood donors and household contacts. The highest levels of both uNO and FeNO were found in household contacts. Less advanced findings on chest x-ray, as well as higher sedimentation rate were observed in HIV+/TB patients as compared to HIV-/TB patients. However, no significant correlation was found between FeNO and uNO, chest x-ray grading, clinical symptoms, TNF-alpha, IL-12, arginine levels or sedimentation rate. CONCLUSION: In both HIV negative and HIV co infected TB patients, low levels of exhaled NO compared to blood donors and household were observed. Future studies are needed to confirm whether low levels of exhaled NO could be a risk factor in acquiring TB and the relative importance of NO in human TB.
format Text
id pubmed-2596154
institution National Center for Biotechnology Information
language English
publishDate 2008
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-25961542008-12-05 Nitric oxide production in the exhaled air of patients with pulmonary tuberculosis in relation to HIV co-infection Idh, Jonna Westman, Anna Elias, Daniel Moges, Feleke Getachew, Assefa Gelaw, Aschalew Sundqvist, Tommy Forslund, Tony Alemu, Addis Ayele, Belete Diro, Ermias Melese, Endalkachew Wondmikun, Yared Britton, Sven Stendahl, Olle Schön, Thomas BMC Infect Dis Research Article BACKGROUND: Nitric oxide (NO) is essential for host defense in rodents, but the role of NO during tuberculosis (TB) in man remains controversial. However, earlier observations that arginine supplementation facilitates anti-TB treatment, supports the hypothesis that NO is important in the host defense against TB. Local production of NO measured in fractional exhaled air (FeNO) in TB patients with and without HIV co-infection has not been reported previously. Thus, our aim was to investigate levels of FeNO in relation to clinical symptoms and urinary NO metabolites (uNO). METHODS: In a cross sectional study, FeNO and uNO were measured and clinical symptoms, chest x-ray, together with serum levels of arginine, tumor necrosis factor alpha (TNF-alpha) and interleukin 12 (IL-12) were evaluated in sputum smear positive TB patients (HIV+/TB, n = 36, HIV-/TB, n = 59), their household contacts (n = 17) and blood donors (n = 46) from Gondar University Hospital, Ethiopia. RESULTS: The proportion of HIV-/TB patients with an increased FeNO level (> 25 ppb) was significantly higher as compared to HIV+/TB patients, but HIV+/TB patients had significantly higher uNO than HIV-/TB patients. HIV+ and HIV-/TB patients both had lower levels of FeNO compared to blood donors and household contacts. The highest levels of both uNO and FeNO were found in household contacts. Less advanced findings on chest x-ray, as well as higher sedimentation rate were observed in HIV+/TB patients as compared to HIV-/TB patients. However, no significant correlation was found between FeNO and uNO, chest x-ray grading, clinical symptoms, TNF-alpha, IL-12, arginine levels or sedimentation rate. CONCLUSION: In both HIV negative and HIV co infected TB patients, low levels of exhaled NO compared to blood donors and household were observed. Future studies are needed to confirm whether low levels of exhaled NO could be a risk factor in acquiring TB and the relative importance of NO in human TB. BioMed Central 2008-10-24 /pmc/articles/PMC2596154/ /pubmed/18950489 http://dx.doi.org/10.1186/1471-2334-8-146 Text en Copyright © 2008 Idh et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Idh, Jonna
Westman, Anna
Elias, Daniel
Moges, Feleke
Getachew, Assefa
Gelaw, Aschalew
Sundqvist, Tommy
Forslund, Tony
Alemu, Addis
Ayele, Belete
Diro, Ermias
Melese, Endalkachew
Wondmikun, Yared
Britton, Sven
Stendahl, Olle
Schön, Thomas
Nitric oxide production in the exhaled air of patients with pulmonary tuberculosis in relation to HIV co-infection
title Nitric oxide production in the exhaled air of patients with pulmonary tuberculosis in relation to HIV co-infection
title_full Nitric oxide production in the exhaled air of patients with pulmonary tuberculosis in relation to HIV co-infection
title_fullStr Nitric oxide production in the exhaled air of patients with pulmonary tuberculosis in relation to HIV co-infection
title_full_unstemmed Nitric oxide production in the exhaled air of patients with pulmonary tuberculosis in relation to HIV co-infection
title_short Nitric oxide production in the exhaled air of patients with pulmonary tuberculosis in relation to HIV co-infection
title_sort nitric oxide production in the exhaled air of patients with pulmonary tuberculosis in relation to hiv co-infection
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2596154/
https://www.ncbi.nlm.nih.gov/pubmed/18950489
http://dx.doi.org/10.1186/1471-2334-8-146
work_keys_str_mv AT idhjonna nitricoxideproductionintheexhaledairofpatientswithpulmonarytuberculosisinrelationtohivcoinfection
AT westmananna nitricoxideproductionintheexhaledairofpatientswithpulmonarytuberculosisinrelationtohivcoinfection
AT eliasdaniel nitricoxideproductionintheexhaledairofpatientswithpulmonarytuberculosisinrelationtohivcoinfection
AT mogesfeleke nitricoxideproductionintheexhaledairofpatientswithpulmonarytuberculosisinrelationtohivcoinfection
AT getachewassefa nitricoxideproductionintheexhaledairofpatientswithpulmonarytuberculosisinrelationtohivcoinfection
AT gelawaschalew nitricoxideproductionintheexhaledairofpatientswithpulmonarytuberculosisinrelationtohivcoinfection
AT sundqvisttommy nitricoxideproductionintheexhaledairofpatientswithpulmonarytuberculosisinrelationtohivcoinfection
AT forslundtony nitricoxideproductionintheexhaledairofpatientswithpulmonarytuberculosisinrelationtohivcoinfection
AT alemuaddis nitricoxideproductionintheexhaledairofpatientswithpulmonarytuberculosisinrelationtohivcoinfection
AT ayelebelete nitricoxideproductionintheexhaledairofpatientswithpulmonarytuberculosisinrelationtohivcoinfection
AT diroermias nitricoxideproductionintheexhaledairofpatientswithpulmonarytuberculosisinrelationtohivcoinfection
AT meleseendalkachew nitricoxideproductionintheexhaledairofpatientswithpulmonarytuberculosisinrelationtohivcoinfection
AT wondmikunyared nitricoxideproductionintheexhaledairofpatientswithpulmonarytuberculosisinrelationtohivcoinfection
AT brittonsven nitricoxideproductionintheexhaledairofpatientswithpulmonarytuberculosisinrelationtohivcoinfection
AT stendahlolle nitricoxideproductionintheexhaledairofpatientswithpulmonarytuberculosisinrelationtohivcoinfection
AT schonthomas nitricoxideproductionintheexhaledairofpatientswithpulmonarytuberculosisinrelationtohivcoinfection